Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2026年9月13日
	新闻
	T-cell engagers in small cell lung cancer - PubMed PubMed The management of small cell lung cancer (SCLC) has been transformed by the advent of effective T-cell engagers (TCEs), which circumvent the ... 标记为不相关
	GSK's Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck Fierce Biotech The ADC achieved median overall survival of 18.5 months in a phase 3 trial, painting it as a threat to Amgen and Merck & Co. in a lung cancer ... 标记为不相关
	Dr Li on Choosing Between a TKI and ADC in HER2-Mutant NSCLC | OncLive OncLive ... Lung Cancer. SEE WHAT THE EXPERTS SAY ->. Newsletter. Stay up to date on ... Bridging the Gaps in Lung Cancer. |. Bridging the Gaps in Lung ... 标记为不相关
	Pumitamig Plus Elfetabart Drozuntecan Elicits 70% ORR Across Lines of Therapy in SCLC OncLive Each agent has previously shown single-agent activity in both SCLC and non–small cell lung cancer (NSCLC), and investigators noted few overlapping ... 标记为不相关
	Dr Liu on Building on the ADRIATIC Regimen in Limited-Stage Small Cell Lung Cancer OncLive “We know that we cure some [patients with limited-stage small cell lung cancer], but not nearly enough. We have better drugs, we have newer agents ... 标记为不相关
	Perioperative Atezolizumab Plus Chemotherapy Extends EFS in Resectable NSCLC OncLive ... Lung Cancer. SEE WHAT THE EXPERTS SAY ->. Rationale for the IMpower030 Trial. Atezolizumab was approved by the US Food and Drug Administration (FDA) ... 标记为不相关
	Obituary for Lori Cadrin - Calgary - Evan J. Strong Funeral Services Evan J. Strong Funeral Services She was a hardworking teammate, cared about the environment throughout her career, and advocated strongly for herself and others fighting lung cancer. 标记为不相关
	Dr Paz-Ares on Managing the Toxicities Associated With Newer Therapies in SCLC OncLive Luis Paz-Ares, MD, PhD, discusses protocols for managing T-cell engager and antibody-drug conjugate toxicities in lung cancer. 标记为不相关
	Local Consolidative Therapy After Dual Immunotherapy Fizzles in Metastatic NSCLC MedPage Today ... lung cancer (NSCLC), including those with oligometastatic disease. In ... lung cancer -- without actionable genomic alteration -- outside of ... 标记为不相关
	Inhibrx Biosciences, Inc. (INBX) SEC Filings, Aug-Oct 2025 - Stock Titan Stock Titan ... oncology studies in chondrosarcoma, colorectal cancer, Ewing sarcoma, head and neck squamous cell carcinoma, and non-small cell lung cancer. The ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈